Amgen's cholesterol-lowering antibody Repatha is being launched in Europe at well below the new drug's cost in the US, raising the chance that American payers will seek hefty discounts on the drug.

and health insurers who include Repatha on their formularies, but the high list price inflated co-payment costs to patients. Now, Amgen is hoping that reducing the co-pay will lead to an ...

We recently published a list of the 11 Best Pharma Stocks to Buy According to Hedge Funds. In this article, we are going to ...

Manufacturing costs are thus pretty low for these companies ... growth trajectory of the company’s rare disease business. Repatha, which treats cholesterol and heart disease, and EVENITY ...

Repatha (evolocumab) is a prescription drug used in certain situations to lower cholesterol and reduce serious heart-related risks. Repatha does this by attaching itself to a protein in your body ...

Recent launches include Repatha (cholesterol-lowering), Aimovig (migraine), Lumakras (lung cancer), and Tezspire (asthma). The 2023 Horizon acquisition brought several rare-disease drugs ...

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up for any (or all) of our 25+ Newsletters. Some states have laws and ethical rules regarding solicitation ...

In other recent news, Amgen reported robust fourth-quarter 2024 results, surpassing market expectations with strong revenue performance driven by key products such as Repatha, Evenity, and Tezspire.

It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several ...

Companies have numerous expenses. Overhead contains the everyday costs that aren't derived from a specific business activity, product, or service. These costs can be substantial, are often very ...

After hours: March 14 at 7:59:44 p.m. EDT Loading Chart for COST ...